Advice Stories
Would you shadow Charles Schwab analysts?
 | over a week ago at Macroaxis By Nico Santiago |
Charles Schwab Corp (SCHW), a prominent player in the Capital Markets industry, has been making headlines recently. Despite the volatility in the market, indicated by a standard deviation of 1.14, the company has managed to maintain a robust operating margin of 33.53%. This is a testament to Schwab's ability to effectively manage its cost of revenue, which stood at $6.2 billion. Continue Reading...
- SCHW Charles Schwab Corp
- Latest Schwab co-chairman sells shares worth over 6.6 million
- SCHW 75.19 -0.04
- Low 74.36
- High 75.55
- Alpha 0.19
- Beta 0.89
- Return On Equity 0.12
- Return On Asset 0.0096
- Profit Margin 0.26 %
- Operating Margin 0.38 %
- Current Valuation 134.82 B
- Shares Outstanding 1.78 B
- Shares Owned By Insiders 6.26 %
- Shares Owned By Institutions 85.55 %
- Number Of Shares Shorted 14.61 M
- Price To Earning 24.36 X
- Price To Book 4.03 X
- Price To Sales 6.79 X
- Revenue 18.84 B
- Gross Profit 20.17 B
- EBITDA 10.62 B
- Net Income 5.07 B
- Cash And Equivalents 40.2 B
- Cash Per Share 48.82 X
- Total Debt 59.97 B
- Debt To Equity 0.71 %
- Current Ratio 0.40 X
- Book Value Per Share 23.23 X
- Cash Flow From Operations (4.17 B)
- Short Ratio 2.02 X
- Earnings Per Share 2.39 X
- Price To Earnings To Growth 1.19 X
- Target Price 77.39
- Number Of Employees 32.6 K
- Beta 1.0
- Market Capitalization 137.37 B
- Total Asset 495.55 B
- Retained Earnings 33.9 B
- Working Capital (115.27 B)
- Current Asset 50 B
- Current Liabilities 165.28 B
- Annual Yield 0.01 %
- Five Year Return 1.19 %
- Net Asset 495.55 B
- Last Dividend Paid 1.0
- Accumulation Distribution 0.0158
- Daily Balance Of Power (0.03)
- Rate Of Daily Change 1.0
- Day Median Price 74.96
- Day Typical Price 75.03
- Market Facilitation Index 1.19
- Price Action Indicator 0.21
- Period Momentum Indicator (0.04)
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Raphi Shpitalnik
Despite Conn's Inc. recent stock price decline, the company's robust revenue of 1.2B and a substantial revenue per share of 49.99 suggest that the current market valuation may not reflect its true potential. However, investors should also consider the company's negative return on assets of 0.06 and a profit margin loss of 0.14, indicating potential financial challenges.
Major Takeaways
Conn's Inc, with a market volatility Beta of 1.69, indicates a somewhat significant risk compared to the market. The company is projected to outperform the market when it rises, but may underperform if the market returns are negative.| over a week ago at Macroaxis By Rifka Kats |  |
In the fast-paced world of biotechnology, one must keep a keen eye on potential investment opportunities. Avid Bioservices, a prominent player in the healthcare industry, is one such company that has been garnering attention from analysts. With a 52-week high of $21.05 and a current 50-day moving average of $7.01, the stock exhibits a high standard deviation of 6.2, indicating a significant level of volatility.
| over two weeks ago at Macroaxis By Rifka Kats | |
Navigating the choppy waters of the stock market can be a daunting task, especially when it comes to companies like Dave & Buster's Entertainment, a key player in the Entertainment industry, listed on NASDAQ. With a total revenue of $2B and a net income of $137.1M, the company has shown its potential in the Hotels, Restaurants & Leisure service category. However, the recent quarterly revenue growth shows a slight dip of 3%.
| over three weeks ago at Macroaxis By Nico Santiago | |
The road to riches is often paved with uncertainty, and America's Car Mart (CRMT) is no exception. Despite being in the Consumer Cyclical sector and the Auto & Truck Dealerships industry, the company has shown a negative income from continuing operations of $20.4M and a net interest income loss of $38.3M. The company's profit margin is also in the red at -0.01, indicating a loss.
| over a month ago at Macroaxis By Gabriel Shpitalnik |  |
Maximize your travel budget with our smart financing tips. Learn to travel more affordably and enjoy premium experiences without overspending.
| over two months ago at Macroaxis By Nico Santiago | |
The article discusses the importance of protecting your financial legacy for future generations. It outlines five crucial steps: engaging wealth management experts, creating a comprehensive estate plan, diversifying investments, educating heirs about money, and intelligent tax planning. This creates a plan that allows for maximum financial legacy protection, and for the wealth to be passed on effectively.
| over three months ago at Macroaxis By Nico Santiago | |
Universal Stainless Alloy (USAP) has shown a steady growth with a potential upside of 7.36% and a Jensen Alpha of 0.65, indicating a good risk-adjusted performance. However, investors should be cautious as the company reported a net income loss of $8.1 million from continuing operations. Despite this, the company's operating margin of 6.19% suggests it has been managing its operating costs effectively.
Main Points
The asset utilization indicator refers to the revenue generated for every dollar of assets a company currently reports.| over three months ago at Macroaxis By Ellen Johnson |  |
RF Industries is currently UNDERVALUED, trading at $3.35 per share, with modest growth projections ahead. We offer trading recommendations to supplement the latest expert consensus on RF Industries. Our advanced recommendation engine employs a multidimensional algorithm to assess the company's growth potential, leveraging all available technical and fundamental data at this time.
Top Findings
RF Industries (USA: RFIL), a prominent player in the Electrical Equipment & Parts industry, presents an enticing investment opportunity based on recent analyst consensus.| over three months ago at Macroaxis By Ellen Johnson | |
When it comes to investing, fortune favors the bold. Praxis Precision Medicines Inc. (NASDAQ: PRAX), a prominent player in the Biotechnology industry, could be on the brink of a breakout performance in February. Despite a negative total risk alpha of -0.61 and a 52-week high of $76.8, the company's robust risk-adjusted performance of 0.118 and a promising analyst overall consensus of 'Buy' suggest a potential upside.
| over three months ago at Macroaxis By Aina Ster |  |